UNSPSC 85494111: Revision of zooplastic tissue in mitral valve, open approach

This classification denotes the group of activities that yields a surgical intervention or procedure to revision of zooplastic tissue in mitral valve, open approach. This surgical intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 02WG08Z

UNSPSC 85494111 Revision of zooplastic tissue in mitral valve, open approach is a Commodity code that, based on recent state and local procurement activity, shows minimal relevant solicitation volume. The code's nominal scope — a specific cardiac surgical procedure using zooplastic (animal-derived) tissue — does not align with the actual work state and local governments are soliciting under this code tag. Recent opportunities posted under 85494111 instead address occupational medical surveillance, disability medical evaluation services, specialty surgical benefit carve-outs for municipal health plans, pharmacy benefit management, and temporary clinical staffing — none of which involve mitral valve surgery or zooplastic tissue revision. The mismatch suggests either miscoding at the issuing-body level or that the code is used as a catchall for healthcare service procurement without precise commodity alignment.

The recent opportunities span state departments (Washington State Department of Transportation), county health systems and government agencies (Santa Clara, Harris County, Collier County), and municipal retirement and benefits offices (City of Phoenix, City of Long Beach), with geographic spread across Arizona, California, Florida, Texas, and Washington. The largest visible contracts include Collier County's pharmacy benefit management RFP (approximately $8.7 million annually in historical spend, with three-year initial term plus two optional renewals) and the City of Phoenix's independent medical evaluation services RFP ($750,000 maximum over five years, due October 16, 2026). Absent substantive alignment between the code's named procedure and the healthcare-services procurement actually tagged with it, the code presents limited targeting utility for firms pursuing mitral valve implant or cardiac device supply contracts. Bidders should verify issuing-body intent and actual scope of work before investing response effort.